C3 glomerulopathy—understanding a rare complement-driven renal disease
The C3 glomerulopathies are a group of rare kidney diseases characterized by complement
dysregulation occurring in the fluid phase and in the glomerular microenvironment, which …
dysregulation occurring in the fluid phase and in the glomerular microenvironment, which …
Complement system part II: role in immunity
NS Merle, R Noe, L Halbwachs-Mecarelli… - Frontiers in …, 2015 - frontiersin.org
The complement system has been considered for a long time as a simple lytic cascade,
aimed to kill bacteria infecting the host organism. Nowadays, this vision has changed and it …
aimed to kill bacteria infecting the host organism. Nowadays, this vision has changed and it …
[HTML][HTML] C3 glomerulopathy: consensus report
MC Pickering, VD D'agati, CM Nester, RJ Smith… - Kidney international, 2013 - Elsevier
C3 glomerulopathy is a recently introduced pathological entity whose original definition was
glomerular pathology characterized by C3 accumulation with absent or scanty …
glomerular pathology characterized by C3 accumulation with absent or scanty …
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
A Schubart, K Anderson, N Mainolfi… - Proceedings of the …, 2019 - National Acad Sciences
Dysregulation of the alternative complement pathway (AP) predisposes individuals to a
number of diseases including paroxysmal nocturnal hemoglobinuria, atypical hemolytic …
number of diseases including paroxysmal nocturnal hemoglobinuria, atypical hemolytic …
Primary glomerulonephritides
J Floege, K Amann - The Lancet, 2016 - thelancet.com
Most glomerulonephritides, even the more common types, are rare diseases. They are
nevertheless important since they frequently affect young people, often cannot be cured, and …
nevertheless important since they frequently affect young people, often cannot be cured, and …
Membranoproliferative glomerulonephritis—a new look at an old entity
S Sethi, FC Fervenza - New England Journal of Medicine, 2012 - Mass Medical Soc
This review discusses the causes, pathogenesis, and clinical management of
membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed …
membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed …
Mechanisms of haemolysis-induced kidney injury
K Van Avondt, E Nur, S Zeerleder - Nature Reviews Nephrology, 2019 - nature.com
Intravascular haemolysis is a fundamental feature of chronic hereditary and acquired
haemolytic anaemias, including those associated with haemoglobinopathies, complement …
haemolytic anaemias, including those associated with haemoglobinopathies, complement …
Eculizumab for dense deposit disease and C3 glomerulonephritis
Results The subjects included three patients with dense deposit disease (including one
patient with recurrent dense deposit disease in allograft) and three patients with C3 …
patient with recurrent dense deposit disease in allograft) and three patients with C3 …
[HTML][HTML] C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
S Sethi, FC Fervenza, Y Zhang, L Zand, JA Vrana… - Kidney international, 2012 - Elsevier
C3 glomerulonephritis (C3GN) is a recently described disorder that typically results from
abnormalities in the alternative pathway (AP) of complement. Here, we describe the clinical …
abnormalities in the alternative pathway (AP) of complement. Here, we describe the clinical …
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis
L Beck, AS Bomback, MJ Choi, LB Holzman… - American Journal of …, 2013 - Elsevier
Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to …
ages throughout the world. Because these disorders are relatively rare, it is difficult to …